Found: 2 articles

Article Edition
Z.G. Luginova (1), O.A. Pogorelova (1), M.I. Tripoten (1), M.V. Koshurnikova (1), T.V. Kuznetsova (1), V.P. Masenko (1), Yu.G. Matchin (1), T.V. Balakhonova (1), A.V. Susekov (2)
MAIN RESULTS OF RANDOMIZED TRIAL "FREGAT"*: EFFECT OF SHORT-TERM INTENSIVE ROSUVASTATIN THERAPY ON CAROTID ATHEROSCLEROSIS IN PATIENTS AT VERY HIGH CARDIOVASCULAR RISK.
№18 / 2016
M.Yu. Zubareva, T.A. Rozhkova, V.A. Amelyushkina; A.V. Susekov, V.V. Kukharchuk
EFFICACY, SAFETY AND TOLERABILITY OF ROSUVASTATIN AT A DOSE OF 40 MG DAILY IN VERY HIGH CARDIOVASCULAR RISK PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA. RESULTS OF 24-WEEK "40 × 40"STUDY
№7 / 2013


Бионика Медиа